MedPath

Quadriceps Sparing Versus Standard Total Knee Arthroplasty

Not Applicable
Completed
Conditions
Knee Osteoarthritis
Knee Arthroplasty
Interventions
Procedure: Medial Para-Patellar Approach
Procedure: Quads-Sparing Approach
Registration Number
NCT03081663
Lead Sponsor
Lawson Health Research Institute
Brief Summary

This study is a randomized clinical trial comparing standard medial para-patellar total knee arthroplasty with a quadriceps sparing mid-vastus approach. Patients who are medically well and have a good support structure at home will be randomized to a standard or quadriceps sparing surgical approach stratified by type of analgesia (adductor canal block or local infiltration). We will compare patient satisfaction and costs from the perspective of the Ministry of Health, the institution, society and the patient.

Detailed Description

Over the past 20 years the length of stay in hospital after total knee replacements has decreased from 9 days to 3 days in Canada and in just the last 10 years the mean length of stay has decreased by half from 6 to 3 days. In order to discharge patients quicker from hospital it's been theorized that less invasive techniques and better, longer lasting anaesthesia are required.

The less invasive quadriceps sparing mid-vastus approach for TKA has been compared to the standard medial para-patellar technique in many studies. Meta-analyses that have looked at studies comparing these approaches have shown some early advantages for quadriceps sparing early post-surgery, but no differences between groups later on and no difference in complications. Early advantages of the mid-vastus approach could potentially allow for earlier and safer discharge from hospital.

Adductor canal block (ACB) and local infiltration analgesia (LIA) form the mainstay of opioid sparing multimodal analgesia for TKA. The nerves of the adductor canal innervate the superficial and deep tissues of the anterior and medial aspects of the knee. ACB has been shown to provide equivalent analgesia while maintaining quadriceps power compared to femoral nerve block (FNB). LIA involves infiltrating the soft tissues of the posterior, lateral and medial aspects of the knee with local anesthetics, ketorolac and morphine. Due to their minimal impact on motor function, ACB and LIA are suitable for fast track TKA.

In combination, quadriceps sparing mid-vastus TKA with ACB may allow patients to be discharged from hospital quicker when compared with standard medial para-patellar TKA with LIA. With our study we aim to investigate whether a quadriceps sparing TKA can provide cost savings without changing complication rates when compared to the current standard of care.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
83
Inclusion Criteria
  • patients requiring primary total knee replacement
  • patients willing and able to comply with follow-up requirements and self-evaluations
  • patients willing to sign an IRB approved informed consent form
  • English fluency (printed instructions are provided in English only)
  • varus arthropathy
  • osteoarthritis
  • ASA less than or equal to 3
  • home/cell phone access
  • adult to accompany patient home post-operatively and to stay with patient for a minimum period of 1-2 days
Read More
Exclusion Criteria
  • patients with inflammatory arthritis
  • patients with a BMI greater than 40 or less than 18
  • patients who are skeletally immature
  • patient with an active infection or suspected latent infection in or about the joint
  • bone stock that is inadequate for support or fixation of the prosthesis
  • hardware precluding intramedullary instrumentation
  • prior osteotomies of the femur or tibia
  • patients living greater than 1.5 hours from the hospital
  • patients without access to caregivers, or unable to go to their home after surgery
  • cognitive or neuromotor conditions
  • patient has significant pain management issues
  • patient/family history of anaesthesia related complications (e.g. malignant hypothermia, pseudocholinesterase deficiency, airway difficulties, obstructive sleep apnea)
  • significant psycho/social issues that would prevent the patient from managing at home safely
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Medial Para-Patellar with TourniquetMedial Para-Patellar ApproachParticipants will undergo total knee arthroplasty with a medial para-patellar approach and a tourniquet. An intramedullary femoral guide and extramedullary tibial guide will be used during the surgery.
Quads-Sparing Approach w/o TourniquetQuads-Sparing ApproachParticipants will have a navigated total knee arthroplasty with a quadriceps-sparing mid-vastus approach and no tourniquet.
Quads-Sparing Approach with TourniquetQuads-Sparing ApproachParticipants will have a navigated total knee arthroplasty with a quadriceps-sparing mid-vastus approach and a tourniquet.
Medial Para-Patellar w/o TourniquetMedial Para-Patellar ApproachParticipants will undergo total knee arthroplasty with a medial para-patellar approach and no tourniquet. An intramedullary femoral guide and extramedullary tibial guide will be used during the surgery.
Primary Outcome Measures
NameTimeMethod
Indirect and Direct Costs of Treatment1 year

ER visits, clinician visits, caregiver lost productivity, tests, etc.

Secondary Outcome Measures
NameTimeMethod
Adverse events1 year

Falls, wound problems, pulmonary embolism, deep vein thrombosis, infection, etc.

Western Ontario McMaster Osteoarthritis Index (WOMAC)1 year

Functional Outcome

Patient Satisfaction Questionnaire2 weeks

Patient satisfaction

Short Form - 12 (SF-12)1 year

Quality of Life

Knee Society Score (KSS)1 year

Functional Outcome

EuroQol-5D (EQ-5D)1 year

Quality of Life

Timed Up and Go Test1 year

Function

Caregiver Strain Index6 weeks

Caregiver Strain

Pain Numeric Rating Scale1 year

Pain

Caregiver Assistance Scale6 weeks

Caregiver Confidence

Trial Locations

Locations (1)

London Health Sciences Centre

🇨🇦

London, Ontario, Canada

© Copyright 2024. All Rights Reserved by MedPath